No free photograph
Tak Wah Mak is read about 24 times a day, in 9 languages.
A typical day, 30 days to 21 September 2026
The middle day of the days counted, so one week of news cannot move it. The line under it is the last 60 days, one point a day.
Something wrong?Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology.
A life in dates
Also in Deutsch
Awards
About this person
Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.
In common with Tak
Ralph M. SteinmanBoth received Novartis Prize for Basic Immunology
Philippa MarrackBoth received Novartis Prize for Basic ImmunologyAnthony PawsonBoth received Robert L. Noble PrizeFrederick AltBoth received Novartis Prize for Basic ImmunologyNahum SonenbergBoth received Robert L. Noble PrizeJack L. StromingerBoth received Novartis Prize for Basic ImmunologyFame.am measures public visibility signals. It does not measure human value, talent, morality, or credibility.